Aagenaes Syndrome

Search Trials
Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years
Status:
Active, not recruiting
Last Changed:
Dec 14, 2021
First Changed:
Nov 30, 2021
Disease(s):
COVID-19
Intervention(s):
COVID-19 Vaccine,Inactivated
A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19
Status:
Not yet recruiting
Last Changed:
Dec 20, 2021
First Changed:
Dec 20, 2021
Disease(s):
COVID-19
Intervention(s):
Tocilizumab
Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19
Status:
Recruiting
Last Changed:
Dec 20, 2021
First Changed:
Dec 20, 2021
Disease(s):
COVID-19
Intervention(s):
BelnacasanPlacebo
Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial
Status:
Not yet recruiting
Last Changed:
Dec 14, 2021
First Changed:
Dec 14, 2021
Disease(s):
COVID-19
Intervention(s):
Adrecizumab (HAM 8101)Placebo
Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 – FORRIF Trial
Status:
Not yet recruiting
Last Changed:
Dec 8, 2021
First Changed:
Nov 26, 2021
Disease(s):
COVID-19
Intervention(s):
Recombinant nonimmunogenic staphylokinasePlacebo

Connect. Empower. Inspire.